
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor microenvironment and nanotherapeutics: intruding the tumor fort
Ammu V. V. V. Ravi Kiran, Garikapati Kusuma Kumari, Praveen Thaggikuppe Krishnamurthy, et al.
Biomaterials Science (2021) Vol. 9, Iss. 23, pp. 7667-7704
Closed Access | Times Cited: 43
Ammu V. V. V. Ravi Kiran, Garikapati Kusuma Kumari, Praveen Thaggikuppe Krishnamurthy, et al.
Biomaterials Science (2021) Vol. 9, Iss. 23, pp. 7667-7704
Closed Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 246
Hailong Tian, Tingting Zhang, Siyuan Qin, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 246
The long and short non-coding RNAs modulating EZH2 signaling in cancer
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 138
Sepideh Mirzaei, Mohammad Gholami, Kiavash Hushmandi, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 138
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
Deep Insight of Design, Mechanism, and Cancer Theranostic Strategy of Nanozymes
Lu Yang, Shuming Dong, Shili Gai, et al.
Nano-Micro Letters (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 65
Lu Yang, Shuming Dong, Shili Gai, et al.
Nano-Micro Letters (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 65
Promising Nanomedicines of Shikonin for Cancer Therapy
Chunmei Yan, Qiuxia Li, Qiang Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1195-1218
Open Access | Times Cited: 37
Chunmei Yan, Qiuxia Li, Qiang Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 1195-1218
Open Access | Times Cited: 37
Phytofabrication of silver nanoparticles using Averrhoa bilimbi leaf extract for anticancer activity
Leena V. Hublikar, Sharanabasava V. Ganachari, Veerabhadragouda B. Patil
Nanoscale Advances (2023) Vol. 5, Iss. 16, pp. 4149-4157
Open Access | Times Cited: 27
Leena V. Hublikar, Sharanabasava V. Ganachari, Veerabhadragouda B. Patil
Nanoscale Advances (2023) Vol. 5, Iss. 16, pp. 4149-4157
Open Access | Times Cited: 27
Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors
Mengzhang Xie, Taojun Gong, Yitian Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4139-4139
Open Access | Times Cited: 15
Mengzhang Xie, Taojun Gong, Yitian Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4139-4139
Open Access | Times Cited: 15
Fmoc-FF hydrogels and nanogels for improved and selective delivery of dexamethasone in leukemic cells and diagnostic applications
Enrico Gallo, Carlo Diaferia, Giovanni Smaldone, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Enrico Gallo, Carlo Diaferia, Giovanni Smaldone, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Inflammation-Driven Nanohitchhiker Enhances Postoperative Immunotherapy by Alleviating Prostaglandin E2-Mediated Immunosuppression
Yingke Liu, Jiao He, Man Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6879-6893
Closed Access | Times Cited: 6
Yingke Liu, Jiao He, Man Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6879-6893
Closed Access | Times Cited: 6
The Application of 2d Mxene Nanosheet -Based Thermosensitive Gel Delivery System Loaded with Cisplatin and Imiquimod for Lung Cancer
Yuwei Ma, Tao Jiang, Rong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4719-4733
Open Access | Times Cited: 6
Yuwei Ma, Tao Jiang, Rong Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4719-4733
Open Access | Times Cited: 6
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Yiming Xu, Jessica C. Hsu, Liyun Xu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Yiming Xu, Jessica C. Hsu, Liyun Xu, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines
Giovanni Smaldone, Elisabetta Rosa, Enrico Gallo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1026-1026
Open Access | Times Cited: 13
Giovanni Smaldone, Elisabetta Rosa, Enrico Gallo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 1026-1026
Open Access | Times Cited: 13
Vascular bursts-mediated tumor accumulation and deep penetration of spherical nucleic acids for synergistic radio-immunotherapy
Jiahao Liu, Lina Guo, Ze Mi, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 1050-1065
Closed Access | Times Cited: 22
Jiahao Liu, Lina Guo, Ze Mi, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 1050-1065
Closed Access | Times Cited: 22
Reactive Oxygen Species‐Mediated Pyroptosis with the Help of Nanotechnology: Prospects for Cancer Therapy
Yuan Ding, Binglin Ye, Zhongquan Sun, et al.
Advanced NanoBiomed Research (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 19
Yuan Ding, Binglin Ye, Zhongquan Sun, et al.
Advanced NanoBiomed Research (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 19
A multi-functional nano-system combining PI3K-110α/β inhibitor overcomes P-glycoprotein mediated MDR and improves anti-cancer efficiency
Ruikun Lin, Lei Zhang, Biwei Ye, et al.
Cancer Letters (2023) Vol. 563, pp. 216181-216181
Closed Access | Times Cited: 11
Ruikun Lin, Lei Zhang, Biwei Ye, et al.
Cancer Letters (2023) Vol. 563, pp. 216181-216181
Closed Access | Times Cited: 11
Optimizing Triple-Negative Breast Cancer Therapy via Ultrasound-Enhanced Piezocatalysis for Targeted Chemodrug Release
Qingwen Xue, Ningning He, Yuxiu Gao, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2779-2796
Open Access
Qingwen Xue, Ningning He, Yuxiu Gao, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2779-2796
Open Access
A glutathione-responsive sulfur dioxide polymer prodrug selectively induces ferroptosis in gastric cancer therapy
Mingjie Xia, Zhihui Guo, Xinming Liu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 15, pp. 4184-4192
Closed Access | Times Cited: 18
Mingjie Xia, Zhihui Guo, Xinming Liu, et al.
Biomaterials Science (2022) Vol. 10, Iss. 15, pp. 4184-4192
Closed Access | Times Cited: 18
Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination
Silvia Pisani, Giulia Bertino, Adriele Prina‐Mello, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 17
Silvia Pisani, Giulia Bertino, Adriele Prina‐Mello, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5363-5363
Open Access | Times Cited: 17
Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery
Farid Hajareh Haghighi, Roya Binaymotlagh, Ilaria Fratoddi, et al.
Gels (2023) Vol. 9, Iss. 12, pp. 953-953
Open Access | Times Cited: 10
Farid Hajareh Haghighi, Roya Binaymotlagh, Ilaria Fratoddi, et al.
Gels (2023) Vol. 9, Iss. 12, pp. 953-953
Open Access | Times Cited: 10
Prognostic value of a glycolysis and cholesterol synthesis related gene signature in osteosarcoma: implications for immune microenvironment and personalized treatment strategies
Jinzhu Feng, Jie Zhang, Yong Chen
ONCOLOGIE (2024) Vol. 26, Iss. 2, pp. 301-310
Open Access | Times Cited: 3
Jinzhu Feng, Jie Zhang, Yong Chen
ONCOLOGIE (2024) Vol. 26, Iss. 2, pp. 301-310
Open Access | Times Cited: 3
Effects of magnetic nanoparticle distribution in cancer therapy through hyperthermia
Assunta Andreozzi, Luca Brunese, Andrea Cafarchio, et al.
International Journal of Thermal Sciences (2024) Vol. 208, pp. 109428-109428
Open Access | Times Cited: 3
Assunta Andreozzi, Luca Brunese, Andrea Cafarchio, et al.
International Journal of Thermal Sciences (2024) Vol. 208, pp. 109428-109428
Open Access | Times Cited: 3
Hybrid cell membranes encapsulated MoS2 nanospheres as an efficient platform for synergetic PTT/PDT and real-time self-evaluation of therapeutic effect
Jiaxin Li, Yanzhi Xing, Leng Han, et al.
Applied Materials Today (2025) Vol. 42, pp. 102609-102609
Closed Access
Jiaxin Li, Yanzhi Xing, Leng Han, et al.
Applied Materials Today (2025) Vol. 42, pp. 102609-102609
Closed Access
Recent advances in smart nanoplatforms for tumor non-interventional embolization therapy
Heng Dong, Dongliang Yang, Yanling Hu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Heng Dong, Dongliang Yang, Yanling Hu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Enhancing the tumor penetration of multiarm polymers by collagenase modification
Bo Yu, Weijie Wang, Yongmin Zhang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 9, pp. 2302-2311
Closed Access | Times Cited: 2
Bo Yu, Weijie Wang, Yongmin Zhang, et al.
Biomaterials Science (2024) Vol. 12, Iss. 9, pp. 2302-2311
Closed Access | Times Cited: 2
Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation
Anna Salvati, Klaas Poelstra
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 217-217
Open Access | Times Cited: 10
Anna Salvati, Klaas Poelstra
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 217-217
Open Access | Times Cited: 10